Sign in
Not yet recruitingNo phase

Gum treatment plus steroid medicine for erosive oral lichen planus

Tests gum cleaning plus glucocorticoids for erosive oral lichen planus.

Key facts

Who runs it
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Periodontal Initial Treatment Combined With Glucocorticoid Therapy for Erosive Oral Lichen Planus
Status
Not yet recruiting
People taking part
29 people, planned
Started
31 Dec 2024
Expected to end
31 Mar 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Periodontal initial treatment under local anesthesia
  • Glucocorticoid Therapy
  • oral hygiene instruction
Record updated
12 July 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with erosive oral lichen planus (painful sore patches inside the mouth) on both sides of the lower back cheek area who also have gum disease (periodontitis).

Age
18 Years to 75 Years
Sex
All sexes can join.
Disease stage
Erosive oral lichen planus lasting more than 2 months. Sores on both sides in the cheek lining and gum groove near the lower back teeth. Sores are mild to moderate: 3mm ≤ longest diameter ≤ 10mm, 9mm2 ≤ total area ≤ 100mm2. Sore size on the two sides differs by no more than ± 25%. Stage II-IV extensive periodontitis.
Earlier treatment
People who had basic gum (periodontal) treatment in the past 6 months cannot join.
Biomarker or test result
In the sore area: plaque index ≥ 3, dental calculus (tartar) index ≥ 2, gingival (gum) index ≥ 2.

Main reasons for not taking part

  • Pregnant or breastfeeding women, or women planning pregnancy during the trial
  • Blood clotting problems or other uncontrolled illness that prevents gum treatment
  • Allergy to local anesthetic drugs such as articaine, or reasons you cannot take glucocorticoids
  • Sores caused by injury or chemical irritation
  • Mental disorders that make it hard to cooperate with treatment

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Existence of erosive oral lichen planus that lasts for more than 2 months
  • Erosive lesions are located in the buccal mucosa and gingival buccal sulcus of the bilateral mandibular posterior teeth area
  • The erosive lesions are mild to moderate (single or multiple small area erosions; 3mm ≤ longest diameter ≤ 10mm; 9mm2 ≤ total area of erosions ≤ 100mm2), and the degree of erosion on both sides is similar (the difference in the size of erosion on both sides does not exceed ± 25%)
  • The plaque index in the area of erosive lesions is ≥ 3; Dental calculus index ≥ 2; Gingival index ≥ 2
  • Accompanied by stage II-IV extensive periodontitis

Who cannot take part

  • Patients with coagulation dysfunction or other uncontrolled systemic diseases who cannot undergo periodontal treatment
  • Individuals with a history of allergy to local anesthetic drugs such as articaine
  • Patients with mental disorders who are difficult to cooperate with treatment
  • Pregnant women, lactating women, or women planning to conceive during the trial period
  • Has undergone basic periodontal treatment within the past 6 months
  • Individuals with contraindications to glucocorticoids
  • Patients with lesion area erosion caused by trauma or chemical stimulation

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this clinical trial is to understand whether the combination of periodontal initial treatment under local anesthesia and glucocorticoids can improve the effectiveness of treatment for erosive oral lichen planus. It will also understand the safety of this treatment regimen.

Read full original descriptionShow less

This study is a single-center, parallel-group, randomized self-controlled trial. The researchers will compare the treatment of periodontal initial therapy combined with glucocorticoid therapy under local anesthesia with traditional glucocorticoid therapy to see if the treatment of periodontal initial therapy combined with glucocorticoid therapy under local anesthesia promotes the healing of erosive oral lichen planus.

Participants will:

One side received periodontal initial treatment combined with glucocorticoid under local anesthesia, while the other side received traditional glucocorticoid therapy Clinical examination at 2, 4, 8, and 12 weeks after treatment Note down the size of their erosion lesion area and periodontal clinical parameters

The 2 groups in the trial

  • Experimental groupTreatment being tested

    In the experimental group, subjects will undergo periodontal initial treatment under local anesthesia combined with glucocorticoid local blockade therapy (such as triamcinolone acetonide injection), local use of triamcinolone acetonide ointment, and 1% sodium bicarbonate rinse (avoiding systemic use during visits) after baseline examination, while receiving the following professional oral hygiene guidance: Instructions and demonstrations for using manual toothbrushes Instructions and demonstrations for using dental floss or interdental brushes A periodontist with rich clinical experience will perform periodontal initial treatment under local anesthesia.

    Treatment: Periodontal initial treatment under local anesthesia, Glucocorticoid Therapy, and oral hygiene instruction

  • Control groupExisting treatment, for comparison

    In the control group, participants will undergo routine glucocorticoid local blockade therapy (such as triamcinolone acetonide injection), local administration of triamcinolone acetonide ointment, and 1% sodium bicarbonate rinse (avoiding systemic medication during visits) after baseline examination, while receiving the following professional oral hygiene guidance: Instructions and demonstrations for using manual toothbrushes Instructions and demonstrations for using dental floss or interdental brushes Based on ethical considerations, all participants will receive full mouth periodontal initial treatment at the end of the trial.

    Treatment: Glucocorticoid Therapy and oral hygiene instruction

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized Self-control Study of Periodontal Initial Treatment Under Local Anesthesia Combined With Glucocorticoid Therapy for Erosive Oral Lichen Planus
Plain-language title
Gum treatment plus steroid medicine for erosive oral lichen planusGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Fit questions
Built from NCT06498180, who can take part
Publications
Record updated
12 July 2024